The Management of Cardiovascular Risk through Epigenetic Biomarkers - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue BioMed Research International Année : 2017

The Management of Cardiovascular Risk through Epigenetic Biomarkers


Epigenetic sciences study heritable changes in gene expression not related to changes in the genomic DNA sequence. The most important epigeneticmechanisms are DNA methylation, posttranslational histone modification, and gene regulation by noncoding RNAs, such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs). Cardiovascular diseases (CVD) are responsible for at least one-third of premature deaths worldwide and represent a heavy burden of healthcare expenditure. We will discuss in this review the most recent findings dealing with epigenetic alterations linked to cardiovascular physiopathology in patients. A particular focus will be put on the way these changes can be translated in the clinic, to develop innovative and groundbreaking biomarkers in CVD field.
Fichier principal
Vignette du fichier
Metzinger et al BMRI 2017.pdf (144.5 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-03584412 , version 1 (18-07-2023)





Laurent Metzinger, Stefano De Franciscis, Raffaele Serra. The Management of Cardiovascular Risk through Epigenetic Biomarkers. BioMed Research International , 2017, 2017, ⟨10.1155/2017/9158572⟩. ⟨hal-03584412⟩
27 Consultations
1 Téléchargements



Gmail Facebook X LinkedIn More